nach oben

CardioVascular and Interventional Radiology

Erschienen in:

01.09.2007 | Clinical Investigation

Follow-up Results of 71 Patients Undergoing Metallic Stent Placement for the Treatment of a Malignant Obstruction of the Superior Vena Cava

verfasst von: Takeshi Nagata, Shiro Makutani, Hideo Uchida, Kimihiko Kichikawa, Munehiro Maeda, Tetsuya Yoshioka, Hiroshi Anai, Hiroshi Sakaguchi, Hitoshi Yoshimura

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 5/2007

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To retrospectively clarify the utility of metallic stent placement for the treatment of the malignant obstruction of the superior vena cava (SVC) in 71 patients with VC syndrome (SVCS) on the basis of long-term follow-up data.

Materials and Methods

Seventy-one patients underwent stent placement and were followed until death. The applicability of the spiral Z-stent (S-Z-stent) mainly used the initial and follow-up results, stent placement for bilateral BCV obstruction and the value of concurrent anticancer therapy were studied.

Results

The technical success rate was 100%, the initial clinical success rate was 87% (62/71), the primary clinical patency rate was 88% (57/65), and the secondary clinical patency rate was 95% (62/65). The obstruction rate of the stent was 12% (8/65), and an additional stent was useful for relief of recurrent SVCS. Survival of 57 patients in whom there was no recurrence of SVCS until death ranged from 1 week to 29 months (mean, 5.4 months and the S-Z-stent appeared to be suitable for the treatment of the malignant obstruction of SVC. Unilateral stent placement was effective for relief of SVCS with bilateral BCV obstruction. Patients who received concurrent anticancer therapy survived 2 months longer than those who did not.

Conclusion

Stent placement is an effective treatment for SVCS. Further, the utility of S-Z-stent for SVCS, an additional stent for recurrence, unilateral stent for patients with bilateral BCV obstruction, and anticancer therapy after stent placement were verified.

Chin DH, Petersen BD, Timmermans H, et al. (1996) Stent-graft in the management of superior vena cava syndrome. Cardiovasc Interv Radiol 19(4):302–304

Dartevelle PG, Chapelier AR, Pastorino U, et al. (1991) Long-term follow-up after prosthetic replacement of the superior vena cava combined with resection of mediastinal-pulmonary malignant tumors. J Thorac Cardiovasc Surg 102(2):259–265PubMed

de Gregorio Ariza MA, Gamboa P, Gimeno MJ, et al. (2003) Percutaneous treatment of superior vena cava syndrome using metallic stents. Eur Radiol 13(4):853–862PubMed

Dyet JF, Nicholson AA, Cook AM (1993) The use of the Wallstent endovascular prosthesis in the treatment of malignant obstruction of the superior vena cava. Clin Radiol 48(6):381–385PubMedCrossRef

Furui S, Sawada S, Kuramoto K, et al. (1995) Gianturco stent placement in malignant caval obstruction: analysis of factors for predicting the outcome. Radiology 195(1):147–152PubMed

Gross CM, Kramer J, Waigand J, et al. (1997) Stent implantation in patients with superior vena cava syndrome. AJR 169(2):429–432PubMed

Hennequin LM, Fade O, Fays JG, et al. (1995) Superior vena cava stent placement: results with the Wallstent endoprosthesis. Radiology 196(2):353–361PubMed

Irving JD, Dondelinger RF, Reidy JF, et al. (1992) Gianturco self-expanding stents: clinical experience in the vena cava and large veins. Cardiovasc Interv Radiol 15(5):328–333

Kee ST, Kinoshita L, Razavi MK, et al. (1998) Superior vena cava syndrome: treatment with catheter-directed thrombolysis and endovascular stent placement. Radiology 206(1):187–193PubMed

10.

Kishi K, Sonomura T, Mitsuzane K, et al. (1993) Self-expandable metallic stent therapy for superior vena cava syndrome: clinical observations. Radiology 189(2):531–535PubMed

11.

Lanciego C, Chacon JL, Julian A, et al. (2001) Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. AJR 177(3):585–593PubMed

12.

Maeda M, Timmermans HA, Uchida BT, et al. (1992) In vitro comparison of the spiral Z stent and the Gianturco Z stent. J Vasc Interv Radiol 3(3):565–569PubMedCrossRef

13.

Miller JH, McBride K, Little F, et al. (2000) Malignant superior vena cava obstruction: stent placement via the subclavian route. Cardiovasc Interv Radiol 23(2):155–158CrossRef

14.

Makutani S, Kichikawa K, Uchida H, et al. (1997) Clinical usefulness of expandable metallic stent for SVC syndrome. Jpn J Phlebol 8(1):51–60

15.

Makutani S, Hamada H, Haku E, et al. (1998) Expandable metallic stent placement for superior vena cava syndrome with obstruction of both brachiocephalic veins: relation between the site of stent placement and clinical efficacy. Jpn IVR 13(1):63–69

16.

Oudkerk M, Kuijpers TJA, Schmitz PIM, et al. (1996) Self-expanding metal stents for palliative treatment of superior vena cava syndrome. Cardiovasc Interv Radiol 19(3):146–151

17.

Nicholson AA, Ettles DF, Arnold A, et al. (1997) Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy. J Vasc Interv Radiol 8(5):781–788PubMedCrossRef

18.

Rosch J, Uchida BT, Hall LD, et al. (1992) Gianturco-Rösch expandable Z-stents in the treatment of superior vena cava syndrome. Cardiovasc Interv Radiol 15(5):319–327

19.

Sawada S, Fujiwara Y, Koyama T, et al. (1992) Application of expandable metallic stents to the venous system. Acta Radiol 33(2):156–159PubMed

20.

Smayra T, Otal P, Chabbert V, et al. (2001) Long-term results of endovascular stent placement in the superior cava venous system. Cardiovasc Interv Radiol 24(6):388–394CrossRef

21.

Smith SL, Manhire AR, Clark DM (2001) Delayed spontaneous superior vena cava perforation associated with a SVC Wallstent. Cardiovasc Interv Radiol 24(4):286–287CrossRef

22.

Takeuchi Y, Arai Y, Kasahara T, et al. (2000) Technical aspects of venous stenting in high-grade stenoses using a long guidewire between dual venous access sites. Eur Radiol 10(1):167–169PubMedCrossRef

23.

Tanaka T, Uemura K, Takahashi M, et al. (1993) Compression of the left brachiocephalic vein: cause of high signal intensity of the left sigmoid sinus and internal jugular vein on MR images. Radiology 188(2):355–361PubMed

24.

Tanigawa N, Sawada S, Mishima K, et al. (1998) Clinical outcome of stenting in superior vena cava syndrome associated with malignant tumors. comparison with conventional treatment. Acta Radiol 39(6):669–674PubMedCrossRef

25.

Dinkel HP, Mettke B, Schmid F, et al. (2003) Endovascular treatment of malignant superior vena cava syndrome: Is bilateral Wallstent placement superior to unilateral placement? J Endovasc Ther 10(4):788–797PubMedCrossRef

26.

Kichikawa K, Uchida H, Maeda M, et al. (2000) Aortic stent-grafting with transrenal fixation: use of newly designed spiral Z-stent endograft. J Endovasc Ther 7(3):184–191PubMedCrossRef

Titel: Follow-up Results of 71 Patients Undergoing Metallic Stent Placement for the Treatment of a Malignant Obstruction of the Superior Vena Cava
verfasst von: Takeshi Nagata
Shiro Makutani
Hideo Uchida
Kimihiko Kichikawa
Munehiro Maeda
Tetsuya Yoshioka
Hiroshi Anai
Hiroshi Sakaguchi
Hitoshi Yoshimura
Publikationsdatum: 01.09.2007
Verlag: Springer-Verlag
Erschienen in: CardioVascular and Interventional Radiology / Ausgabe 5/2007
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-007-9088-4

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Follow-up Results of 71 Patients Undergoing Metallic Stent Placement for the Treatment of a Malignant Obstruction of the Superior Vena Cava